MedTrace Logo

A Study of Cognitive Health in Survivors of Prostate Cancer

NCT05540782 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-10-09

No results posted yet for this study

Summary

The purpose of this study is to collect information that may help the researchers understand the relationship between prostate cancer survivors' experiences of cancer-related cognitive dysfunction (CRCD) and their other conditions (co-morbid factors), including anxiety, depression, and insomnia. The researchers will also find out how additional things may contribute to CRCD, including social factors, the characteristics of participants' prostate cancer, and the type of cancer treatment or other medications they received.

Conditions

Interventions

BEHAVIORAL

PROMIS-SF v2.0 -Cognitive Function 8a

Patient-Reported Outcomes (PROs)

Sponsors & Collaborators

Principal Investigators

  • Kevin Liou · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-08
Primary Completion
2026-09-08
Completion
2026-09-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05540782 on ClinicalTrials.gov